Price T Rowe Associates Inc Surmodics Inc Transaction History

Price T Rowe Associates Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$28.84 - $38.92 $23,043 - $31,097	799 Added 10.49%	8,419 $256,000
Q2 2022 Aug 15, 2022	BUY	$33.25 - $45.11 $2,660 - $3,608	80 Added 1.06%	7,620 $284,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $68,098 - $83,231	-1,674 Reduced 18.17%	7,540 $342,000
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $154,821 - $206,380	-3,583 Reduced 28.0%	9,214 $444,000
Q3 2021 Nov 15, 2021	BUY	$52.8 - $60.32 $3,590 - $4,101	68 Added 0.53%	12,797 $712,000
Q2 2021 Aug 16, 2021	SELL	$51.29 - $59.15 $44,365 - $51,164	-865 Reduced 6.36%	12,729 $691,000
Q1 2021 May 17, 2021	BUY	$42.18 - $56.07 $54,454 - $72,386	1,291 Added 10.49%	13,594 $762,000
Q4 2020 Feb 16, 2021	BUY	$35.18 - $43.52 $432,819 - $535,426	12,303 New	12,303 $535,000

128

11.8M

1.4K

8.6K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.